Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications
Mattia Galli
, Francesco Franchi
, Fabiana Rollini
, Luis Ortega-Paz
, Domenico D’Amario
, Raffaele De Caterina
, Roxana Mehran
, C. Michael Gibson
, Dominick J. Angiolillo
Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review
Fingerprint
Entra nei temi di ricerca di 'Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications'. Insieme formano una fingerprint unica.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science